Study finds no increased risk of malformation following first trimester pseudoephedrine exposure
Researchers affiliated to the School of Public Health at Ben-Gurion University of the Negev (Beer-Sheva, Israel), have published the results of a study conducted using Clalit Health Services insurance claims data investigating malformation risks following maternal first trimester pseudoephedrine use. The results indicated that fetal exposure was not an independent risk factor for major congenital malformations, either overall or by […]
» Read more